CMS Hospital Compare Site Updated

The Hospital Compare site launched by the Centers for Medicare and Medicaid Services (CMS) was expanded by the organization. The site was given a complete overhaul and new datapoints were added. CMS noted one benefit of enhancing the site is providing consumers with the most up-to-date information when considering hospitals for treatment.

The updated website now includes pediatric-related data related to asthma care. Those include inpatient treatment with corticosteroids and relievers for inpatient asthma. More than 25 process of care and ten patient satisfaction measures were also incorporated.

Also added was a pneumonia-related measure, which is supported by both the National Quality Forum (NQF) and the Hospital Quality Alliance (HQA). That specifically considers the 30-day mortality rate, which is akin to the measure that already exists for heart attack and heart failure.

All three of the 30-day mortality measures were modified to include risk-standardized mortality rate. Addition of this provides a benchmark for consumers as a way to determine if hospitals have improved outcomes over time.

The two mortality measures for heart failure and attack were added almost a year ago. In that time period, data assessment indicates that the national 30-day mortality rate dropped from 16.3 to 16.1 percent.

The Hospital Compare site was created to allow consumers to compare quality-related data from local hospitals. It was initially launched in March 2005.

August 21, 2008 Related topics: Quality, Safety, Errors

Today on
Hospital Buyer

HospitalBuyer Undergoing Surgery

HospitalBuyer is on long-term hiatus. We may come back in new and improved form in the future, but...

CT Scans Alter ER Decision-Making About Appendicitis

Data collected from CT scanning of the abdomen and pelvis can alter decision-making by clinicians regarding those patients...

MediNotes Purchase Completed by Eclipsys

Eclipsys Corporation announced that the acquisition (pdf) of MediNotes was finalized. MediNotes is now a wholly owned subsidiary...